These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21393811)

  • 41. Accelerated chondrocyte functions on NaOH-treated PLGA scaffolds.
    Park GE; Pattison MA; Park K; Webster TJ
    Biomaterials; 2005 Jun; 26(16):3075-82. PubMed ID: 15603802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gelation dynamics and gel structure of fibrinogen.
    Kubota K; Kogure H; Masuda Y; Toyama Y; Kita R; Takahashi A; Kaibara M
    Colloids Surf B Biointerfaces; 2004 Nov; 38(3-4):103-9. PubMed ID: 15542309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.
    Lafont J; Jacques C; Le Dreau G; Calhabeu F; Thibout H; Dubois C; Berenbaum F; Laurent M; Martinerie C
    J Bone Miner Res; 2005 Dec; 20(12):2213-23. PubMed ID: 16294274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibrin gel formation in a shear flow.
    Guy RD; Fogelson AL; Keener JP
    Math Med Biol; 2007 Mar; 24(1):111-30. PubMed ID: 17018571
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Potential of chondrogenesis of bone marrow stromal cells co-cultured with chondrocytes on biodegradable scaffold: in vivo experiment with pigs and mice].
    Liu X; Zhou GD; Lü XJ; Liu TY; Zhang WJ; Liu W; Cao YL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1929-33. PubMed ID: 17923021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibrin as a cell carrier in cardiovascular tissue engineering applications.
    Mol A; van Lieshout MI; Dam-de Veen CG; Neuenschwander S; Hoerstrup SP; Baaijens FP; Bouten CV
    Biomaterials; 2005 Jun; 26(16):3113-21. PubMed ID: 15603806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A reproducible, high throughput method for fabricating fibrin gels.
    Murphy KC; Leach JK
    BMC Res Notes; 2012 Aug; 5():423. PubMed ID: 22873708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis.
    He S; Bark N; Wang H; Svensson J; Blombäck M
    J Cardiovasc Pharmacol; 2009 Jan; 53(1):24-9. PubMed ID: 19129740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An indium:calcium phosphate colloid that specifically targets fibrin.
    Makowski GS; Ramsby ML; Ramsby GR
    J Biomed Sci; 2005; 12(2):421-9. PubMed ID: 15918002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibrin-based tissue engineering: comparison of different methods of autologous fibrinogen isolation.
    Dietrich M; Heselhaus J; Wozniak J; Weinandy S; Mela P; Tschoeke B; Schmitz-Rode T; Jockenhoevel S
    Tissue Eng Part C Methods; 2013 Mar; 19(3):216-26. PubMed ID: 22889109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibroblast migration in fibrin gel matrices.
    Brown LF; Lanir N; McDonagh J; Tognazzi K; Dvorak AM; Dvorak HF
    Am J Pathol; 1993 Jan; 142(1):273-83. PubMed ID: 8424460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dry-cured ham restructured with fibrin.
    Romero de Ávila MD; Hoz L; Ordóñez JA; Cambero MI
    Food Chem; 2014 Sep; 159():519-28. PubMed ID: 24767091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Interaction of fibrinogen with magnetite nanoparticles].
    Bychkova AV; Sorokina ON; Kovarskiĭ AL; Shapiro AB; Leonova VB; Rozenfel'd MA
    Biofizika; 2010; 55(4):605-11. PubMed ID: 20968070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The effect of "aging" of fibrinogen molecule on the structure and properties of fibrin gel].
    Rozenfel'd MA; Leonova VB; Biriukova MI
    Izv Akad Nauk Ser Biol; 2007; (4):394-401. PubMed ID: 17966900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incorporation of exudates of human platelet-rich fibrin gel in biodegradable fibrin scaffolds for tissue engineering of cartilage.
    Chien CS; Ho HO; Liang YC; Ko PH; Sheu MT; Chen CH
    J Biomed Mater Res B Appl Biomater; 2012 May; 100(4):948-55. PubMed ID: 22279009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PRP-fibrinogen gel-like chondrocyte carrier stabilized by TXA-preliminary study.
    Sitek P; Wysocka-Wycisk A; Kępski F; Król D; Bursig H; Dyląg S
    Cell Tissue Bank; 2013 Mar; 14(1):133-40. PubMed ID: 22212703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of iron oxide nanoparticles on fibrin gel formation and its fractal dimension.
    Kirichenko MN; Chaikov LL; Krivokhizha SV; Kirichenko AS; Bulychev NA; Kazaryan MA
    J Chem Phys; 2019 Apr; 150(15):155103. PubMed ID: 31005110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Behavior of human dermal fibroblasts in three-dimensional fibrin clots: dependence on fibrinogen and thrombin concentration.
    Cox S; Cole M; Tawil B
    Tissue Eng; 2004; 10(5-6):942-54. PubMed ID: 15265312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation.
    Blombäck B; Carlsson K; Fatah K; Hessel B; Procyk R
    Thromb Res; 1994 Sep; 75(5):521-38. PubMed ID: 7992253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controlled preparation of thin fibrin films immobilized at solid surfaces.
    Riedel T; Brynda E; Dyr JE; Houska M
    J Biomed Mater Res A; 2009 Feb; 88(2):437-47. PubMed ID: 18306296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.